AI-generated summary
The authors studied whether laser photobiomodulation at 830 nm or 660 nm affects the survival of a musculocutaneous flap in rats, with and without nicotine exposure. They report that 830 nm irradiation was associated with a smaller area of necrosis, more mast cells, and higher VEGF and CD34 expression. The study was conducted in rats, so the findings may not apply directly to people.
- Participants
- 60
- Who or what was studied
- Albino Wistar rats (60 animals in six groups of ten), with and without nicotine exposure
- Wavelengths
- 830, 660 nm
- Limits stated in the abstract
- The study was conducted in rats and the abstract does not describe clinical outcomes in humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 830 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Photobiomodulation, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.